Journey Medical (DERM) Asset Writedowns and Impairment (2020 - 2025)
Historic Asset Writedowns and Impairment for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $76000.0.
- Journey Medical's Asset Writedowns and Impairment fell 8867.36% to $76000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$477000.0, marking a year-over-year decrease of 15795.87%. This contributed to the annual value of $516000.0 for FY2024, which is 8358.26% down from last year.
- Per Journey Medical's latest filing, its Asset Writedowns and Impairment stood at $76000.0 for Q3 2025, which was down 8867.36% from -$441000.0 recorded in Q2 2025.
- In the past 5 years, Journey Medical's Asset Writedowns and Impairment ranged from a high of $3.1 million in Q2 2023 and a low of -$441000.0 during Q2 2025
- Moreover, its 5-year median value for Asset Writedowns and Impairment was $70000.0 (2021), whereas its average is $232176.5.
- As far as peak fluctuations go, Journey Medical's Asset Writedowns and Impairment soared by 1003870.97% in 2023, and later plummeted by 40205.48% in 2025.
- Over the past 5 years, Journey Medical's Asset Writedowns and Impairment (Quarter) stood at $115000.0 in 2021, then skyrocketed by 138.26% to $274000.0 in 2022, then surged by 1047.08% to $3.1 million in 2023, then plummeted by 109.77% to -$307000.0 in 2024, then skyrocketed by 124.76% to $76000.0 in 2025.
- Its last three reported values are $76000.0 in Q3 2025, -$441000.0 for Q2 2025, and $195000.0 during Q1 2025.